南美洲和中美洲成瘾治疗市场预测至 2027 年 - COVID-19 影响和按治疗类型划分的区域分析(尼古丁成瘾治疗、酒精成瘾治疗、阿片类药物成瘾治疗、其他药物成瘾治疗);药物类型(伐尼克兰、安非他酮、尼古丁替代产品、丁丙诺啡、纳曲酮、双硫仑等);治疗中心(门诊治疗中心、住院治疗中心、住院治疗中心);分销渠道(医院、药店、其他)和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 83    |    Report Code: TIPRE00017279    |    Category: Life Sciences

South and Central America Addictions Therapeutics Market

市场介绍

成瘾是一种心理和身体上无法停止消费毒品、酒精、阿片类药物和相关类别物质的行为,尽管这些物质有各种精神和身体危害。成瘾会使人对服用该物质产生依赖性。所以,要戒毒,有多种选择,比如药物治疗、康复治疗,可以更好的戒毒。

 

市场概况和动态

南美洲和中美洲成瘾治疗市场预计预计将从 2019 年的 3.3254 亿美元增至 2027 年的 4.8204 亿美元。预计 2020 年至 2027 年,该市场将以 4.9% 的复合年增长率增长。市场的增长归因于新药批准的增加和数字疗法的推出治疗毒瘾、开展各种宣传活动以及政府努力打击药物滥用和推广药物治疗。然而,与药物开发相关的高成本阻碍了成瘾治疗市场的增长。

 

主要细分市场

根据治疗类型,南美洲和中美洲成瘾治疗市场分为尼古丁成瘾治疗、酒精成瘾治疗、阿片类成瘾治疗、和其他物质成瘾治疗。 2019年,尼古丁成瘾治疗领域占据了最大的市场份额,预计在预测期内复合年增长率最高。

南美洲和中美洲成瘾治疗市场按药物类型分为伐尼克兰、安非他酮、尼古丁替代产品、丁丙诺啡、纳曲酮、双硫仑等。伐尼克兰细分市场在 2019 年占据最大的市场份额。然而,预计尼古丁替代产品细分市场在预测期内的复合年增长率最高。

按治疗中心划分中南美洲成瘾治疗市场分为门诊治疗中心、住院治疗中心和住院治疗中心。 2019年,门诊治疗中心细分市场占有最大的市场份额,预计该细分市场在预测期内的复合年增长率最高。

南部和南部地区中美洲成瘾治疗市场根据分销渠道分为医院药房、医疗商店等。医院药房细分市场在 2019 年占据最大市场份额,预计医疗商店细分市场在预测期内的复合年增长率最高。

 

主要来源和列出的公司

一些与本报告有关的南美洲和中美洲成瘾治疗市场相关的主要和次要来源是卫生部卫生部阿根廷 (ANMAT); 疾病控制和预防中心(CDC); 以及世界卫生组织 (WHO) 等。

 

< em>购买报告的理由

  • 根据详细信息确定潜在投资领域未来几年南美洲和中美洲成瘾治疗市场趋势分析。
  • 深入了解推动支出最高的国家/地区不同成瘾治疗药物细分市场需求的根本因素,并确定以下领域提供的机会:
  • 加强您对市场需求驱动因素、行业趋势和最新技术发展等方面的了解。
  • 确定推动南美洲和中美洲 成瘾治疗市场的主要渠道,提供清晰地了解未来的机会,这将有助于分析,从而扩大收入。
  • 通过关注不同国家/地区正在进行的项目来引导资源南美洲和中美洲 成瘾治疗市场。

 

 

南美洲和中美洲成瘾治疗市场细分

 按治疗类型

  • 阿片类药物成瘾治疗
  • 酒精成瘾治疗
  • 尼古丁成瘾治疗
  • 其他物质成瘾治疗

 

按药物类型

  • 丁丙诺啡
  • 纳曲酮< /span>
  • 安非他酮
  • 双硫仑
  • 尼古丁替代产品
  • 伐尼克兰
  • 其他

 

按治疗中心

  • 住院治疗中心
  • 住院治疗中心
  • 门诊治疗中心

 

按分销渠道划分

  • 医院药房
  • 医疗商店
  • 其他

 

按国家

  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区

 < /span>

公司简介

  • 独立PLC
  • < li>葛兰素史克公司
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Hikma Pharmaceuticals PLC
 

South and Central America Addictions Therapeutics Strategic Insights

Strategic insights for South and Central America Addictions Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-addictions-therapeutics-market-strategic-framework.webp
Get more information on this report

South and Central America Addictions Therapeutics Report Scope

Report Attribute Details
Market size in 2019 US$ 332.54 Million
Market Size by 2027 US$ 482.04 Million
Global CAGR (2020 - 2027) 4.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 治疗类型
  • 尼古丁成瘾治疗
  • 酒精成瘾治疗
  • 阿片类药物成瘾治疗
  • 其他物质成瘾治疗
By 药物类型
  • 伐尼克兰
  • 安非他酮
  • 尼古丁替代产品
  • 丁丙诺啡
  • 纳曲酮
  • 双硫仑
By 治疗中心
  • 门诊治疗中心
  • 住院治疗中心
  • 住院治疗中心
By 分销渠道
  • 医院
  • 药店
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Indivior PLC
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Hikma Pharmaceuticals PLC
  • Get more information on this report

    South and Central America Addictions Therapeutics Regional Insights

    The regional scope of South and Central America Addictions Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-addictions-therapeutics-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Addictions Therapeutics Market

    1. Indivior PLC
    2. GlaxoSmithKline plc
    3. Bausch Health Companies Inc
    4. Cipla Inc.
    5. Hikma Pharmaceuticals PLC
    Frequently Asked Questions
    How big is the South and Central America Addictions Therapeutics Market?

    The South and Central America Addictions Therapeutics Market is valued at US$ 332.54 Million in 2019, it is projected to reach US$ 482.04 Million by 2027.

    What is the CAGR for South and Central America Addictions Therapeutics Market by (2020 - 2027)?

    As per our report South and Central America Addictions Therapeutics Market, the market size is valued at US$ 332.54 Million in 2019, projecting it to reach US$ 482.04 Million by 2027. This translates to a CAGR of approximately 4.9% during the forecast period.

    What segments are covered in this report?

    The South and Central America Addictions Therapeutics Market report typically cover these key segments-

  • 治疗类型 (尼古丁成瘾治疗, 酒精成瘾治疗, 阿片类药物成瘾治疗, 其他物质成瘾治疗)
  • 药物类型 (伐尼克兰, 安非他酮, 尼古丁替代产品, 丁丙诺啡, 纳曲酮, 双硫仑)
  • 治疗中心 (门诊治疗中心, 住院治疗中心, 住院治疗中心)
  • What is the historic period, base year, and forecast period taken for South and Central America Addictions Therapeutics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Addictions Therapeutics Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South and Central America Addictions Therapeutics Market?

    The South and Central America Addictions Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Indivior PLC
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Hikma Pharmaceuticals PLC
  • Who should buy this report?

    The South and Central America Addictions Therapeutics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Addictions Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.